Global Patent Index - EP 3864034 A1

EP 3864034 A1 20210818 - CELL

Title (en)

CELL

Title (de)

ZELLE

Title (fr)

CELLULE

Publication

EP 3864034 A1 20210818 (EN)

Application

EP 19791327 A 20191007

Priority

  • GB 201816399 A 20181008
  • GB 2019052829 W 20191007

Abstract (en)

[origin: WO2020074868A1] The present invention relates to a cell which co-expresses (i) a dominant-negative SMAD (dnSMAD); and (ii).a chimeric antigen receptor (CAR) or a transgenic T-cell receptor (TCR).

IPC 8 full level

C07K 14/725 (2006.01); C07K 14/705 (2006.01); C12N 5/071 (2010.01)

CPC (source: EP US)

A61K 39/4611 (2023.05 - EP US); A61K 39/4631 (2023.05 - EP US); A61K 39/464471 (2023.05 - EP US); C07K 14/7051 (2013.01 - EP); C07K 14/70521 (2013.01 - EP); C12N 5/0636 (2013.01 - EP US); C12N 2501/515 (2013.01 - EP); C12N 2510/00 (2013.01 - EP)

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

DOCDB simple family (publication)

WO 2020074868 A1 20200416; EP 3864034 A1 20210818; GB 201816399 D0 20181128

DOCDB simple family (application)

GB 2019052829 W 20191007; EP 19791327 A 20191007; GB 201816399 A 20181008